From left to right: Shirin A. Enger (Assistant Professor) and Gabriel Famulari (PhD Candidate)
The motivation behind design and development of novel brachytherapy radiation sources is the possibility to shield the radiation sources locally, maximising the radiation dose to the tumour with less dose spillage to radiation sensitive healthy tissues. Additionally, less shielding will be required for the treatment rooms, enabling more cancer centres to offer brachytherapy as a treatment modality to their patients. In this project new radiation sources for use in high dose rate brachytherapy with much lower energy than the currently used radiation source, Iridium-192, are investigated and developed.
Peer reviewed publications and published conference presentations
2017
Journal publications
- Famulari G, Urlich T, Armstrong A, Enger SA, Practical aspects of 153Gd as a radioactive source for use in brachytherapy. Applied Radiation and Isotopes. 130:131–139 (2017).
Conference presentations
Poster presentations
-
Famulari G, Armstrong A, Urlich T, Enger SA, Production of Gd-153 as a source isotope for use in rotating shield high dose rate brachytherapy. Radiotherapy and Oncology, 119:S472 (2016).